<DOC>
	<DOCNO>NCT00176917</DOCNO>
	<brief_summary>The purpose study determine safety engraftment donor hematopoietic cell use condition regimen patient undergo hematopoietic ( blood forming ) cell transplant Hurler syndrome , Maroteaux Lamy syndrome , Mannosidosis , I-cell disease .</brief_summary>
	<brief_title>Stem Cell Transplantation Hurler</brief_title>
	<detailed_description>Prior transplantation , subject receive Busulfan intravenously ( IV ) via Hickman line four time daily 4 day , Cyclophosphamide intravenously via Hickman line day 4 day , Anti-Thymocyte Globulin IV via Hickman line twice daily three day transplant . These three drug give subject help new marrow `` take '' grow . On day transplantation , donor 's hematopoietic cell transfuse via central venous catheter . After hematopoietic cell transplant , subject receive two drug , cyclosporin either methylprednisolone Mycophenolate Mofetil ( MMF ) . Cyclosporin methylprednisolone MMF give help prevent complication graft-versus-host disease decrease chance new donor cell reject .</detailed_description>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mannosidase Deficiency Diseases</mesh_term>
	<mesh_term>alpha-Mannosidosis</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<mesh_term>Mucolipidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis VI</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Patients Mucopolysaccharidosis , type I ( e.g. , Hurler syndrome ) , MaroteauxLamy syndrome ( MPS VI ) , Alpha Mannosidosis , mucolipidosis type II ( Icell disease ) HLAidentical mismatch ( 1 antigen ) relate marrow , PBSC , cord blood donor . Patients Mucopolysaccharidosis , type I , MaroteauxLamy syndrome ( MPS VI ) , Alpha Mannosidosis , mucolipidosis type II ( Icell disease ) HLAidentical HLA1 antigen mismatch unrelated marrow , PBSC , HLA02 antigen mismatch umbilical cord blood donor . Patients MPS type I , Maroteaux Lamy Syndrome ( MPS VI ) , mucolipidosis type II ( Icell disease ) mental developmental index within two standard deviation normal mean , best determine use Bayley scale infant development standardized testing , recognize may affect speech and/or hear impairment . Adequate organ function : Cardiac : ejection fraction &gt; 40 % ; decompensated congestive heart failure uncontrolled arrhythmia Renal : serum creatinine &lt; 2.0 mg/dl Hepatic : total bilirubin &lt; 3x Upper limit normal transaminase &lt; 5.0 x Upper limit normal Signed consent . Presence major organ dysfunction ( see ) Pregnancy Evidence HIV infection know HIV positive serology Patients parent psychologically incapable undergo BMT associate strict isolation document history medical noncompliance Patients &gt; 50 kg may risk cell dos goal â‰¥ 10 x 106 CD 34 cells/kg therefore eligible receive unrelated PBSCs .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>stem cell transplant</keyword>
	<keyword>storage disease</keyword>
	<keyword>error metabolism</keyword>
</DOC>